Short-Term Oral Administration of Mesoporous Silica Nanoparticles Potentially Induced Colon Inflammation in Rats Through Alteration of Gut Microbiota

References

• Farjadian F, Ghasemi A, Gohari O, Roointan A, Karimi M, Hamblin MR. Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities. Nanomedicine. 2019;14(1):93–126. doi:10.2217/nnm-2018-0120
   PubMed Web of Science ®Google Scholar
• Zhan J, Ma Z, Wang D, et al. Magnetic and pH dual-responsive mesoporous silica nanocomposites for effective and low-toxic photodynamic therapy. Int J Nanomedicine. 2017;Volume 12:2733–2748. doi:10.2147/IJN.S127528
   PubMedGoogle Scholar
• Taqanaki ER, Heidari R, Monfared M, Tayebi L, Azadi A, Farjadian F. EDTA-modified mesoporous silica as supra adsorbent of copper ions with novel approach as an antidote agent in copper toxicity. Int J Nanomedicine. 2019;14:7781–7792. doi:10.2147/IJN.S218760
   PubMed Web of Science ®Google Scholar
• Mehmood Y, Khan IU, Shahzad Y, et al. In-vitro and in-vivo evaluation of velpatasvir-loaded mesoporous silica scaffolds. A prospective carrier for drug bioavailability enhancement. Pharmaceutics. 2020;12(4):307. doi:10.3390/pharmaceutics12040307
   PubMedGoogle Scholar
• Yang G, Li Z, Wu F, et al. Improving solubility and bioavailability of breviscapine with mesoporous silica nanoparticles prepared using ultrasound-assisted solution-enhanced dispersion by supercritical fluids method. Int J Nanomedicine. 2020;15:1661–1675. doi:10.2147/IJN.S238337
   PubMed Web of Science ®Google Scholar
• Tran VA, Vo VG, Shim K, Lee SW, An SSA. Multimodal mesoporous silica nanocarriers for dual stimuli-responsive drug release and excellent photothermal ablation of cancer cells. Int J Nanomedicine. 2020;Volume 15:7667–7685. doi:10.2147/IJN.S254344
   Google Scholar
• Farjadian F, Roointan A, Mohammadi-Samani S, Hosseini M. Mesoporous silica nanoparticles: synthesis, pharmaceutical applications, biodistribution, and biosafety assessment. Chem Eng J. 2019.
   Google Scholar
• Garcia-Bennett AE. Synthesis, toxicology and potential of ordered mesoporous materials in nanomedicine. Nanomedicine. 2011;6(5):867–877. doi:10.2217/nnm.11.82
   PubMedGoogle Scholar
• Fu C, Liu T, Li L, Liu H, Chen D, Tang F. The absorption, distribution, excretion and toxicity of mesoporous silica nanoparticles in mice following different exposure routes. Biomaterials. 2013;34(10):2565–2575. doi:10.1016/j.biomaterials.2012.12.043
   PubMed Web of Science ®Google Scholar
• Li L, Liu T, Fu C, Tan L, Meng X, Liu H. Biodistribution, excretion, and toxicity of mesoporous silica nanoparticles after oral administration depend on their shape. Nanomedicine. 2015;11(8):1915–1924. doi:10.1016/j.nano.2015.07.004
   PubMed Web of Science ®Google Scholar
• Chen L, Guo Y, Hu C, Lam PKS, Lam JCW, Zhou B. Dysbiosis of gut microbiota by chronic coexposure to titanium dioxide nanoparticles and bisphenol A: implications for host health in zebrafish. Environ Pollut. 2018;234:307–317. doi:10.1016/j.envpol.2017.11.074
   PubMedGoogle Scholar
• Wilding LA, Bassis CM, Walacavage K, et al. Repeated dose (28-day) administration of silver nanoparticles of varied size and coating does not significantly alter the indigenous murine gut microbiome. Nanotoxicology. 2016;10(5):513–520. doi:10.3109/17435390.2015.1078854
   PubMed Web of Science ®Google Scholar
• Wu SH, Lin HP. Synthesis of mesoporous silica nanoparticles. Chem Soc Rev. 2013;42(9):3862–3875. doi:10.1039/c3cs35405a
   PubMed Web of Science ®Google Scholar
• Zhao D, Feng J, Huo Q, et al. Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores. Science (80-). 1998;279(5350):548–552. doi:10.1126/science.279.5350.548
   PubMed Web of Science ®Google Scholar
• Shen D, Yang J, Li X, et al. Biphase stratification approach to three-dimensional dendritic biodegradable mesoporous silica nanospheres. Nano Lett. 2014;14(2):923–932. doi:10.1021/nl404316v
   PubMed Web of Science ®Google Scholar
• Köchling T, Sanz JL, Gavazza S, Florencio L. Analysis of microbial community structure and composition in leachates from a young landfill by 454 pyrosequencing. Appl Microbiol Biotechnol. 2015;99(13):5657–5668. doi:10.1007/s00253-015-6409-4
   PubMedGoogle Scholar
• Kozich JJ, Westcott SL, Baxter NT, Highlander SK, Schloss PD. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the miseq illumina sequencing platform. Appl Environ Microbiol. 2013;79(17):5112–5120. doi:10.1128/AEM.01043-13
   PubMed Web of Science ®Google Scholar
• Martínez-Carmona M, Gun’ko YK, Vallet-Regí M. Mesoporous silica materials as drug delivery: “the nightmare” of bacterial infection. Pharmaceutics. 2018;10(4):279. doi:10.3390/pharmaceutics10040279
   PubMed Web of Science ®Google Scholar
• González B, Colilla M, Díez J, et al. Mesoporous silica nanoparticles decorated with polycationic dendrimers for infection treatment. Acta Biomater. 2018;68:261–271. doi:10.1016/j.actbio.2017.12.041
   PubMed Web of Science ®Google Scholar
• Mohammadi H, Seyyed RH, Niknezhad V, Jamshidzadeh A, Farjadian F. In vitro and in vivo evaluation of succinic acid-substituted mesoporous silica for ammonia adsorption: potential application in the management of hepatic encephalopathy. Int J Nanomedicine. 2020;15:10085–10098. doi:10.2147/IJN.S271883
   PubMed Web of Science ®Google Scholar
• Dogra P, Adolphi NL, Wang Z, et al. Establishing the effects of mesoporous silica nanoparticle properties on in vivo disposition using imaging-based pharmacokinetics. Nat Commun. 2018;9(1). doi:10.1038/s41467-018-06730-z.
   Google Scholar
• Yu T, Hubbard D, Ray A, Ghandehari H. In vivo biodistribution and pharmacokinetics of silica nanoparticles as a function of geometry, porosity and surface characteristics. J Control Release. 2012;163(1):46–54. doi:10.1016/j.jconrel.2012.05.046
   PubMed Web of Science ®Google Scholar
• Yu T, Malugin A, Ghandehari H. Impact of silica nanoparticle design on cellular toxicity and hemolytic activity. ACS Nano. 2011;5(7):5717–5728. doi:10.1021/nn2013904
   PubMed Web of Science ®Google Scholar
• Hong X, Zhong X, Du G, et al. The pore size of mesoporous silica nanoparticles regulates their antigen delivery efficiency. Sci Adv. 2020;6(25):eaaz4462. doi:10.1126/sciadv.aaz4462
   PubMed Web of Science ®Google Scholar
• Huang X, Li L, Liu T, et al. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. ACS Nano. 2011;5(7):5390–5399. doi:10.1021/nn200365a
   PubMed Web of Science ®Google Scholar
• He Q, Zhang Z, Gao F, Li Y, Shi J. In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation. Small. 2011;7(2):271–280. doi:10.1002/smll.201001459
   PubMed Web of Science ®Google Scholar
• Clarridge JE. Impact of 16S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases. Clin Microbiol Rev. 2004;17(4):840–862. doi:10.1128/CMR.17.4.840-862.2004
   PubMed Web of Science ®Google Scholar
• Caporaso JG, Lauber CL, Walters WA, et al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc Natl Acad Sci U S A. 2011;108(Supplement_1):4516–4522. doi:10.1073/pnas.1000080107
   PubMed Web of Science ®Google Scholar
• Langille MGI, Zaneveld J, Caporaso JG, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol. 2013;31(9):814–821. doi:10.1038/nbt.2676
   PubMed Web of Science ®Google Scholar
• Chauhan S, Manivasagam G, Kumar P, Ambasta RK. Cellular toxicity of mesoporous silica nanoparticle in SHSY5Y and BMMNCs cell. Pharm Nanotechnol. 2018;6(4):245–252. doi:10.2174/2211738506666181031160108
   PubMedGoogle Scholar
• Tarn D, Ashley CE, Xue M, Carnes EC, Zink JI, Brinker CJ. Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility. Acc Chem Res. 2013;46(3):792–801. doi:10.1021/ar3000986
   PubMed Web of Science ®Google Scholar
• Lehman SE, Morris AS, Mueller PS, Salem AK, Grassian VH, Larsen SC. Silica nanoparticle-generated ROS as a predictor of cellular toxicity: mechanistic insights and safety by design. Environ Sci Nano. 2016;3(1):56–66. doi:10.1039/C5EN00179J
   PubMed Web of Science ®Google Scholar
• Ferrari B, Winsley T, Ji M, Neilan B. Insights into the distribution and abundance of the ubiquitous candidatus Saccharibacteria phylum following tag pyrosequencing. Sci Rep. 2014;4. doi:10.1038/srep03957
   Google Scholar
• Williams K, Milner J, Boudreau MD, Gokulan K, Cerniglia CE, Khare S. Effects of subchronic exposure of silver nanoparticles on intestinal microbiota and gut-associated immune responses in the ileum of Sprague-Dawley rats. Nanotoxicology. 2015;9(3):279–289. doi:10.3109/17435390.2014.921346
   PubMed Web of Science ®Google Scholar
• Pan H, Guo R, Zhu J, et al. A gene catalogue of the Sprague-Dawley rat gut metagenome. Gigascience. 2018;7(5). doi:10.1093/gigascience/giy055.
   Web of Science ®Google Scholar
• Paranjpe M, Müller-Goymann CC. Nanoparticle-mediated pulmonary drug delivery: a review. Int J Mol Sci. 2014;15(4):5852–5873. doi:10.3390/ijms15045852
   PubMed Web of Science ®Google Scholar
• Li XX, Shi S, Rong L, Feng MQ, Zhong L. The impact of liposomal linolenic acid on gastrointestinal microbiota in mice. Int J Nanomedicine. 2018;13:1399–1409. doi:10.2147/IJN.S151825
   PubMed Web of Science ®Google Scholar
• Kuehbacher T, Rehman A, Lepage P, et al. Intestinal TM7 bacterial phylogenies in active inflammatory bowel disease. J Med Microbiol. 2008;57(12):1569–1576. doi:10.1099/jmm.0.47719-0
   PubMedGoogle Scholar
• Fujio-Vejar S, Vasquez Y, Morales P, et al. The gut microbiota of healthy chilean subjects reveals a high abundance of the phylum verrucomicrobia. Front Microbiol. 2017;8. doi:10.3389/fmicb.2017.01221
   PubMedGoogle Scholar